Results 161 to 170 of about 147,555 (214)

Minimal mutational requirements for conversion of a telomere resolvase into a Cre-like site-specific recombinase. [PDF]

PLoS One
Huang SH, Kobryn K.
europepmc   +1 more source

Flavonoids identified in Australian <i>Terminalia</i> inhibit methicillin and β-lactam-resistant pathogens, exhibit efflux pump inhibitory activity, and potentiate conventional antibiotics. [PDF]

Microbiol Spectr
Jawad Yousaf Zai M, Cheesman MJ, Cock IE.   +2 more
europepmc   +1 more source

DNA Scission by Non-Histidine Amino-Terminal Cu(II) and Ni(II) Binding-Like Peptides. [PDF]

Chembiochem
Müller LK, Zhdanova H, Unksov IN, Gräwe A, Stahl J, Stein V, Tietze D, Tietze AA.   +7 more
europepmc   +1 more source

Comparative <i>in vitro</i> study of <i>Coleus amboinicus</i> and paclitaxel on oral cancer cells. [PDF]

J Oral Maxillofac Pathol
Yugashini C, Prabhu S, Prabhu A.
europepmc   +1 more source

Encapsulin-Protected Immunotherapeutic Complexes: Bacteria-Derived Nanoparticles for mRNA Delivery to Eukaryotic Cells. [PDF]

ChemMedChem
Coffeen CF, Cayetano-Cruz M, Ilhuicatzi-Alvarado D, Méndez C, Moreno-Fierros L, Bustos-Jaimes I.   +5 more
europepmc   +1 more source

Dual Targeting Strategy: Colchicine and Paclitaxel Combination Against Prostate Cancer Cells Colchicine-Paclitaxel Synergy in Prostate Cancer. [PDF]

Medeni Med J
Sumer C, Sari C, Aras M, Usta DD.
europepmc   +1 more source

Antimicrobial susceptibility and adaptative changes in MRSA lineages exposed to increasing concentrations of fluoroquinolones and chlorhexidine. [PDF]

Sci Rep
de Oliveira TLR, de Souza AF, de Souza BM, da Silva MG, Duarte RS, Ferreira RBR, Dos Santos KRN.   +6 more
europepmc   +1 more source

Investigating the material basis and molecular mechanisms of <i>Oldenlandia diffusa</i> in the treatment of papillary thyroid carcinoma: a network pharmacology and experimental study. [PDF]

Transl Cancer Res
Ding C, Shi TF, Kong XJ, Dong JY, Liu YM, Zhao YH.   +5 more
europepmc   +1 more source